DRI Researchers Publish in Leading Peer-Reviewed Journals

DRI Researchers Publish in Leading Peer-Reviewed Journals

New Findings Support the Use of IL-2 Therapy in Patients with Type 1 Diabetes  New Findings Support the Use of IL-2 Therapy in Patients with Type 1 Diabetes  Dr. Alberto Pugliese, professor of medicine, immunology and microbiology and head of the DRI’s Immunogenetics...